Zacks Research Lowers Earnings Estimates for Avantor

Avantor, Inc. (NYSE:AVTR) – Research analysts at Zacks Research decreased their FY2025 EPS estimates for shares of Avantor in a research note issued on Wednesday, November 19th. Zacks Research analyst Team now expects that the company will post earnings per share of $0.91 for the year, down from their previous forecast of $0.96. The consensus estimate for Avantor’s current full-year earnings is $1.06 per share. Zacks Research also issued estimates for Avantor’s Q4 2025 earnings at $0.22 EPS, Q1 2026 earnings at $0.20 EPS, Q2 2026 earnings at $0.23 EPS, Q3 2026 earnings at $0.23 EPS, Q4 2026 earnings at $0.23 EPS, FY2026 earnings at $0.89 EPS, Q1 2027 earnings at $0.22 EPS, Q2 2027 earnings at $0.21 EPS and FY2027 earnings at $1.00 EPS.

Avantor (NYSE:AVTR) last posted its quarterly earnings results on Wednesday, October 29th. The company reported $0.22 EPS for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.01). Avantor had a positive return on equity of 10.91% and a negative net margin of 1.25%.The company had revenue of $1.62 billion during the quarter, compared to analyst estimates of $1.65 billion. During the same quarter in the previous year, the business posted $0.26 earnings per share. The company’s revenue for the quarter was down 5.3% compared to the same quarter last year. Avantor has set its FY 2025 guidance at 0.880-0.920 EPS.

AVTR has been the topic of several other research reports. Royal Bank Of Canada cut their price target on Avantor from $20.00 to $17.00 and set an “outperform” rating on the stock in a report on Monday, August 4th. Robert W. Baird increased their target price on Avantor from $15.00 to $17.00 and gave the stock an “outperform” rating in a report on Friday, October 24th. UBS Group set a $12.00 price target on shares of Avantor in a research note on Thursday, October 30th. Evercore ISI lowered their price objective on shares of Avantor from $16.00 to $14.00 and set an “outperform” rating on the stock in a report on Thursday, October 30th. Finally, Stifel Nicolaus set a $12.00 price objective on shares of Avantor and gave the company a “hold” rating in a report on Monday, August 4th. Four investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $14.42.

Avantor Stock Performance

Shares of AVTR opened at $11.55 on Friday. Avantor has a one year low of $10.82 and a one year high of $23.32. The company has a market cap of $7.87 billion, a PE ratio of -88.81, a P/E/G ratio of 3.78 and a beta of 1.00. The stock has a 50-day moving average of $12.82 and a 200-day moving average of $12.99. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.49 and a quick ratio of 0.96.

Insiders Place Their Bets

In other news, Director Gregory L. Summe purchased 100,000 shares of the business’s stock in a transaction that occurred on Thursday, October 30th. The shares were acquired at an average cost of $11.25 per share, for a total transaction of $1,125,000.00. Following the completion of the acquisition, the director owned 300,000 shares in the company, valued at $3,375,000. This trade represents a 50.00% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 1.20% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of AVTR. Victory Capital Management Inc. raised its holdings in Avantor by 10.0% during the 1st quarter. Victory Capital Management Inc. now owns 353,836 shares of the company’s stock valued at $5,736,000 after acquiring an additional 32,222 shares during the period. Allianz Asset Management GmbH raised its holdings in Avantor by 4.4% in the first quarter. Allianz Asset Management GmbH now owns 45,700 shares of the company’s stock worth $741,000 after purchasing an additional 1,932 shares in the last quarter. HighPoint Advisor Group LLC bought a new position in Avantor in the 1st quarter worth about $206,000. Universal Beteiligungs und Servicegesellschaft mbH lifted its holdings in shares of Avantor by 34.1% during the first quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 363,496 shares of the company’s stock valued at $5,892,000 after purchasing an additional 92,414 shares in the last quarter. Finally, Royce & Associates LP bought a new stake in shares of Avantor during the 1st quarter valued at about $671,000. 95.08% of the stock is owned by institutional investors.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.